Perivalvular sealing for transcatheter heart valve

US11020222B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11020222-B2
Application numberUS-201916554014-A
CountryUS
Kind codeB2
Filing dateAug 28, 2019
Priority dateJul 15, 2011
Publication dateJun 1, 2021
Grant dateJun 1, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A prosthetic heart valve includes a frame, a valvular structure coupled to the frame, and a sealing member coupled to the frame. The frame has inflow and outflow ends and a lumen extending therebetween. The frame includes struts that form cells, and the cells are arranged in three rows. The frame is radially expandable from a collapsed state to an expanded state. The valvular structure includes a plurality of leaflets configured to allow blood flow through the lumen of the frame from the inflow end to the outflow end and to block blood flow through the lumen of the frame from the outflow end to the inflow end. The sealing skirt extends from an intermediate location of the frame disposed between the inflow and outflow ends to the inflow end of the frame. The sealing skirt covers two rows of cells to block blood flow through the cells.

First claim

Opening claim text (preview).

We claim: 1. An assembly comprising: a prosthetic heart valve comprising a frame, a valvular structure, and a sealing member, wherein the frame has an inflow end, an outflow end, and a longitudinal axis extending from the inflow end to the outflow end, wherein the frame comprises exactly four circumferentially-extending rows of angled struts, wherein the angled struts are part of exactly three circumferentially-extending rows of hexagonal cells, wherein the valvular structure is coupled to the frame and comprises exactly three leaflets, wherein the sealing member is coupled to the frame and at least substantially covers two of the three rows of hexagonal cells, and wherein one of the three rows of hexagonal cell is at least partially uncovered by the sealing member, wherein portions of the annular sealing member are configured to protrude radially outwardly through the hexagonal cells to seal against native tissue; and a delivery apparatus comprising an inflatable balloon, wherein the prosthetic heart valve is mounted on the balloon of the delivery apparatus with the prosthetic heart valve in a radially collapsed state, and wherein the balloon is configured to be inflated to radially expand the prosthetic heart valve from the radially collapsed state to a radially expanded state within a patient's native aortic valve. 2. The assembly of claim 1 , wherein each of the hexagonal cells includes: two opposing side struts that are spaced apart from each other and extend parallel to the longitudinal axis; a first pair of angled struts extending from respective first ends of the side struts away from the outflow end and converging to intersect with each other; and a second pair of angled struts extending from respective second ends of the side struts and away from the inflow end and converging to intersect with each other. 3. The assembly of claim 2 , wherein each leaflet has a tab portion adjacent a free edge of the leaflet and a scalloped edge portion opposite the free edge, wherein the tab portion is coupled to the frame at a location adjacent the outflow end of the frame, and wherein the scalloped edge portion is secured to the sealing member by sutures. 4. The assembly of claim 2 , wherein the frame of the prosthetic heart valve is comprises nickel-based alloy, wherein the sealing member comprises PET fabric, and wherein the delivery apparatus is configured to deliver the prosthetic heart valve to the patient's native aortic valve using a transfemoral delivery procedure.

Assignees

Inventors

Classifications

  • using balloon catheter · CPC title

  • sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable · CPC title

  • A61F2/2418Primary

    Scaffolds therefor, e.g. support stents · CPC title

  • Deployment by retracting a sheath · CPC title

  • telescopic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11020222B2 cover?
A prosthetic heart valve includes a frame, a valvular structure coupled to the frame, and a sealing member coupled to the frame. The frame has inflow and outflow ends and a lumen extending therebetween. The frame includes struts that form cells, and the cells are arranged in three rows. The frame is radially expandable from a collapsed state to an expanded state. The valvular structure includes…
Who is the assignee on this patent?
Edwards Lifesciences Corp
What technology area does this patent fall under?
Primary CPC classification A61F2/2418. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).